eli lilly and company weight loss drug

Eli Lilly, Zepbound and Obesity Drug

Eli Lilly Cuts Price of Weight-Loss Drug Zepbound for Self-Pay Patients

Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new available vial doses.

FOX News on MSN · 2d

Eli Lilly cuts prices for Zepbound weight-loss drug again

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of tirzepatide,

Forbes · 1d

InnovationRx: Eli Lilly Has Stockpiled Nearly $550 Million Of Its Next Obesity Drug

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, the growing measles outbreak in Texas,

Lilly to invest $27 billion in new US plants

CNN on MSN · 1d

Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States, shoring up domestic manufacturing as President Donald Trump threatens new tariffs on pharmaceuticals.

USA Today · 1d

Lilly to invest $27 billion in new US plants as Trump threatens pharmaceutical tariffs

The new plants will be built over the next five years, and are expected to create more than 3,000 jobs for skilled workers.

The Hill on MSN · 1d

Eli Lilly to spend up to $27 billion in new domestic plants amid Trump tariff threat

Drugmaker Eli Lilly plans to invest up to $27 billion to build four new pharmaceutical manufacturing sites in the U.S., the company announced Wednesday, a move that comes as President Trump is threatening import tariffs on pharmaceuticals.

2don MSN

Eli Lilly to Offer Higher Doses of Obesity Drug Zepbound at Discounted Prices

Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.

6don MSN

New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.

Weight-loss drugs such as Ozempic and Zepbound cost $900 to $1,500 for a month's supply.They cost so much partly because of ...

ConsumerAffairs2d

Eli Lilly is offering weight loss drug Zepbound at lower prices

Eli Lilly is lowering the cost barrier to its weight loss drug Zepbound. For many consumers, their insurance denies them ...

Lilly offers weight-loss drugs in vials at a discount to fight competition

Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range ...

Eli Lilly Introduces New Weight Loss Drug Doses, Lowers Price Points

Eli Lilly & Co. said Tuesday that it has launched new doses of its obesity treatment drug and reduced its prices. The pharmaceutical company said it has launched 7.5 and 10 milligram single-dose vials ...

Wall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk

Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as ...

Eli Lilly (LLY) Lowers Prices for Weight Loss Drug Zepbound

U.S. pharmaceutical giant Eli Lilly (LLY) is lowering the cost of its blockbuster weight loss medication Zepbound in an effort to reach more ...

FiercePharma3d

Lilly banks stockpile of oral GLP-1 drug with potential launch still more than a year away

Eli Lilly was second to the lucrative GLP-1 market for diabetes and obesity following its chief metabolic medicine rival Novo ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results